Skip Nav Destination
Issues
1 August 2008
-
Cover Image
Cover Image
Human glioblastoma multiforme (GBM) and control brain specimens were analyzed for expression of Protein Inhibitor of Activated STATs (PIAS)-3, a negative regulator of STAT-3. PIAS3 expression was largely absent in GBM tissue compared with control tissue. For further details, please see Brantley and coworkers on page 4694 in this issue.
- PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Editor's Note
CCR Translations
Perspectives
Human Cancer Biology
Delineation of TMPRSS2-ERG Splice Variants in Prostate Cancer
Ying Hu; Albert Dobi; Taduru Sreenath; Christopher Cook; Atekelt Y. Tadase; Lakshmi Ravindranath; Jennifer Cullen; Bungo Furusato; Yongmei Chen; Rajesh L. Thangapazham; Ahmed Mohamed; Chen Sun; Isabell A. Sesterhenn; David G. McLeod; Gyorgy Petrovics; Shiv Srivastava
Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors
Michael L. Nickerson; Erich Jaeger; Yangu Shi; Jeffrey A. Durocher; Sunil Mahurkar; David Zaridze; Vsevolod Matveev; Vladimir Janout; Hellena Kollarova; Vladimir Bencko; Marie Navratilova; Neonilia Szeszenia-Dabrowska; Dana Mates; Anush Mukeria; Ivana Holcatova; Laura S. Schmidt; Jorge R. Toro; Sara Karami; Rayjean Hung; Gary F. Gerard; W. Marston Linehan; Maria Merino; Berton Zbar; Paolo Boffetta; Paul Brennan; Nathaniel Rothman; Wong-Ho Chow; Frederic M. Waldman; Lee E. Moore
Imaging, Diagnosis, Prognosis
Prospective Study of the Accuracy of EGFR Mutational Analysis by High-Resolution Melting Analysis in Small Samples Obtained from Patients with Non–Small Cell Lung Cancer
Tomoya Fukui; Yuichiro Ohe; Koji Tsuta; Koh Furuta; Hiromi Sakamoto; Toshimi Takano; Hiroshi Nokihara; Noboru Yamamoto; Ikuo Sekine; Hideo Kunitoh; Hisao Asamura; Takaaki Tsuchida; Masahiro Kaneko; Masahiko Kusumoto; Seiichiro Yamamoto; Teruhiko Yoshida; Tomohide Tamura
The Retinoblastoma Family Member pRb2/p130 Is an Independent Predictor of Survival in Human Soft Tissue Sarcomas
Valeria Masciullo; Ester Berardengo; Antonella Boglione; Alessandro Sgambato; Amelia Bernardi; Marco Forni; Alessandra Linari; Letizia Cito; Giovanni Scambia; Alessandro Comandone; Antonio Giordano
Three-Gene Expression Signature Predicts Survival in Early-Stage Squamous Cell Carcinoma of the Lung
Marcin Skrzypski; Ewa Jassem; Miquel Taron; Jose Javier Sanchez; Pedro Mendez; Witold Rzyman; Grazyna Gulida; Dan Raz; David Jablons; Mariano Provencio; Bartomeu Massuti; Imane Chaib; Laia Perez-Roca; Jacek Jassem; Rafael Rosell
Cancer Therapy: Clinical
K-Ras Mutations and Treatment Outcome in Colorectal Cancer Patients Receiving Exclusive Fluoropyrimidine Therapy
Marie-Christine Etienne-Grimaldi; Jean-Louis Formento; Mireille Francoual; Eric François; Patricia Formento; Nicole Renée; Pierre Laurent-Puig; Maurice Chazal; Daniel Benchimol; Jean-Robert Delpero; Christian Letoublon; Denis Pezet; Jean-François Seitz; Gérard Milano
A Phase I Trial of the Oral, Multikinase Inhibitor Sorafenib in Combination with Carboplatin and Paclitaxel
Keith T. Flaherty; Joan Schiller; Lynn M. Schuchter; Glenn Liu; David A. Tuveson; Maryann Redlinger; Chetan Lathia; Chenghua Xia; Oana Petrenciuc; Sunil R. Hingorani; Michael A. Jacobetz; Patricia A. Van Belle; David Elder; Marcia S. Brose; Barbara L. Weber; Mark R. Albertini; Peter J. O'Dwyer
Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal Cancer
Howard L. Kaufman; Heinz-Josef Lenz; John Marshall; Deepti Singh; Chris Garett; Christine Cripps; Malcolm Moore; Margaret von Mehren; Richard Dalfen; William J. Heim; Robert M. Conry; Walter J. Urba; Al B. Benson, III; Maria Yu; Judy Caterini; Seunghee Kim-Schulze; Mark DeBenedette; Danielle Salha; Thorsten Vogel; Ileana Elias; Neil L. Berinstein
A Pilot Study of Consolidative Immunotherapy in Patients with High-Risk Pediatric Sarcomas
Crystal L. Mackall; Eunice H. Rhee; Elizabeth J. Read; Hanh M. Khuu; Susan F. Leitman; Donna Bernstein; Merertu Tesso; Lauren M. Long; David Grindler; Margret Merino; William Kopp; Maria Tsokos; Jay A. Berzofsky; Lee J. Helman
Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma
Jill A. Maxwell; Stewart P. Johnson; Roger E. McLendon; David W. Lister; Krystle S. Horne; Ahmed Rasheed; Jennifer A. Quinn; Francis Ali-Osman; Allan H. Friedman; Paul L. Modrich; Darell D. Bigner; Henry S. Friedman
Cancer Therapy: Preclinical
Efficacy of Systemically Administered Mutant Vesicular Stomatitis Virus (VSVΔ51) Combined with Radiation for Nasopharyngeal Carcinoma
Nehad M. Alajez; Joseph D. Mocanu; Wei Shi; Marie C. Chia; Caroline J. Breitbach; Angela B.Y. Hui; Shane Knowles; John C. Bell; Pierre Busson; Kenzo Takada; Kwok-Wai Lo; Brian O'Sullivan; Pat Gullane; Fei-Fei Liu
Radiation-Mediated Up-Regulation of Gene Expression from Replication-Defective Adenoviral Vectors: Implications for Sodium Iodide Symporter Gene Therapy
Mohan Hingorani; Christine L. White; Shane Zaidi; Andrew Merron; Inge Peerlinck; Martin E. Gore; Christopher M. Nutting; Hardev S. Pandha; Alan A. Melcher; Richard G. Vile; Georges Vassaux; Kevin J. Harrington
Human Mena+11a Isoform Serves as a Marker of Epithelial Phenotype and Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Pancreatic Cancer Cell Lines
Maria S. Pino; Michele Balsamo; Francesca Di Modugno; Marcella Mottolese; Massimo Alessio; Elisa Melucci; Michele Milella; David J. McConkey; Ulrike Philippar; Frank B. Gertler; Pier Giorgio Natali; Paola Nisticò
Telomere Maintenance in Laser Capture Microdissection–Purified Barrett's Adenocarcinoma Cells and Effect of Telomerase Inhibition In vivo
Masood A. Shammas; Aamer Qazi; Ramesh B. Batchu; Robert C. Bertheau; Jason Y.Y. Wong; Manjula Y. Rao; Madhu Prasad; Diptiman Chanda; Selvarangan Ponnazhagan; Kenneth C. Anderson; Christopher P. Steffes; Nikhil C. Munshi; Immaculata De Vivo; David G. Beer; Sergei Gryaznov; Donald W. Weaver; Raj K. Goyal
Cancer Prevention and Susceptibility
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds